News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,291 Results
Type
Article (49093)
Company Profile (231)
Press Release (544967)
Multimedia
Podcasts (96)
Webinars (10)
Section
Business (159709)
Career Advice (3080)
Deals (28974)
Drug Delivery (107)
Drug Development (78576)
Employer Resources (178)
FDA (14435)
Job Trends (12648)
News (286684)
Policy (27733)
Tag
Academia (2502)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (80)
Alliances (42785)
ALS (93)
Alzheimer's disease (1294)
Antibody-drug conjugate (ADC) (153)
Approvals (14424)
Artificial intelligence (264)
Autoimmune disease (25)
Automation (14)
Bankruptcy (255)
Best Places to Work (10372)
BIOSECURE Act (18)
Biosimilars (100)
Biotechnology (168)
Bladder cancer (84)
Brain cancer (31)
Breast cancer (303)
Cancer (2409)
Cardiovascular disease (163)
Career advice (2593)
Career pathing (34)
CAR-T (165)
Cell therapy (434)
Cervical cancer (21)
Clinical research (63588)
Collaboration (819)
Compensation (450)
Complete response letters (30)
COVID-19 (2562)
CRISPR (40)
C-suite (213)
Cystic fibrosis (97)
Data (2152)
Decentralized trials (1)
Denatured (23)
Depression (48)
Diabetes (233)
Diagnostics (5909)
Digital health (17)
Diversity (7)
Diversity, equity & inclusion (42)
Drug discovery (119)
Drug pricing (97)
Drug shortages (20)
Duchenne muscular dystrophy (87)
Earnings (64784)
Editorial (41)
Employer branding (25)
Employer resources (154)
Events (93831)
Executive appointments (623)
FDA (15589)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (682)
Gene editing (102)
Generative AI (24)
Gene therapy (311)
GLP-1 (715)
Government (4476)
Grass and pollen (6)
Guidances (52)
Healthcare (16883)
Huntington's disease (22)
IgA nephropathy (29)
Immunology and inflammation (121)
Indications (30)
Infectious disease (2702)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (92)
Interviews (619)
IPO (14587)
IRA (37)
Job creations (2683)
Job search strategy (2113)
Kidney cancer (11)
Labor market (35)
Layoffs (401)
Leadership (24)
Legal (5250)
Liver cancer (81)
Lung cancer (345)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (274)
MASH (66)
Medical device (10302)
Medtech (10306)
Mergers & acquisitions (14942)
Metabolic disorders (663)
Multiple sclerosis (80)
NASH (23)
Neurodegenerative disease (92)
Neuropsychiatric disorders (28)
Neuroscience (1829)
NextGen: Class of 2025 (5741)
Non-profit (4093)
Now hiring (35)
Obesity (350)
Opinion (248)
Ovarian cancer (78)
Pain (78)
Pancreatic cancer (86)
Parkinson's disease (139)
Partnered (19)
Patents (213)
Patient recruitment (110)
Peanut (42)
People (43800)
Pharmaceutical (60)
Pharmacy benefit managers (16)
Phase I (20133)
Phase II (28111)
Phase III (20835)
Pipeline (1171)
Policy (136)
Postmarket research (2281)
Preclinical (8653)
Press Release (52)
Prostate cancer (113)
Psychedelics (32)
Radiopharmaceuticals (262)
Rare diseases (384)
Real estate (4187)
Recruiting (72)
Regulatory (20045)
Reports (41)
Research institute (2324)
Resumes & cover letters (498)
Rett syndrome (5)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (123)
Series B (73)
Service/supplier (10)
Sickle cell disease (52)
Special edition (18)
Spinal muscular atrophy (144)
Sponsored (30)
Startups (3072)
State (2)
Stomach cancer (16)
Supply chain (55)
Tariffs (36)
The Weekly (71)
Vaccines (710)
Venture capitalists (37)
Weight loss (246)
Women's health (29)
Worklife (20)
Date
Today (143)
Last 7 days (796)
Last 30 days (2441)
Last 365 days (30936)
2025 (9983)
2024 (33238)
2023 (37849)
2022 (48387)
2021 (52204)
2020 (50069)
2019 (41752)
2018 (31647)
2017 (29667)
2016 (28361)
2015 (33079)
2014 (25140)
2013 (20527)
2012 (21173)
2011 (21721)
2010 (19875)
Location
Africa (817)
Alabama (51)
Alaska (6)
Arizona (128)
Arkansas (10)
Asia (39922)
Australia (6741)
California (5663)
Canada (1967)
China (520)
Colorado (240)
Connecticut (252)
Delaware (147)
Europe (81946)
Florida (806)
Georgia (180)
Idaho (41)
Illinois (457)
India (22)
Indiana (272)
Iowa (9)
Japan (161)
Kansas (94)
Kentucky (19)
Louisiana (10)
Maine (67)
Maryland (840)
Massachusetts (4269)
Michigan (198)
Minnesota (295)
Mississippi (1)
Missouri (78)
Montana (29)
Nebraska (18)
Nevada (50)
New Hampshire (56)
New Jersey (1641)
New Mexico (24)
New York (1644)
North Carolina (869)
North Dakota (6)
Northern California (2496)
Ohio (172)
Oklahoma (9)
Oregon (32)
Pennsylvania (1190)
Puerto Rico (9)
Rhode Island (22)
South America (1044)
South Carolina (20)
Southern California (2137)
Tennessee (65)
Texas (821)
United States (21061)
Utah (163)
Virginia (131)
Washington D.C. (50)
Washington State (531)
West Virginia (2)
Wisconsin (52)
594,291 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite Reports 2024 Financial Results and Clinical Update
April 14, 2025
·
12 min read
Press Releases
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
February 5, 2025
·
5 min read
Press Releases
Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
April 15, 2025
·
5 min read
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
Can-Fite BioPharma Ltd. announces that its VP of Business Development, Dr. Sari Fishman, will hold 23 partnering meetings with Biotech & Pharma companies, who showed interest in partnering with Can-Fite.
May 27, 2024
·
5 min read
Press Releases
Can-Fite: FDA Approved Compassionate Use Treatment with Namodenoson in a Pancreatic Cancer Patient
March 19, 2025
·
5 min read
Drug Development
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
Can-Fite BioPharma Ltd. today announced an update on the status of its oncological lead drug candidate, Namodenoson in the treatment of advanced liver cancer.
June 5, 2024
·
6 min read
Press Releases
Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
March 19, 2025
·
9 min read
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6
Can-Fite BioPharma Ltd. is pleased to invite investors to a webinar on June 6, 2024, at 4:15 p.m. ET.
May 23, 2024
·
5 min read
Press Releases
Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients
April 17, 2025
·
6 min read
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announces that company scientists came up with breakthrough findings showing that the anti-cancer and protective effects in the liver are conferred via the signalling protein adiponectin.
June 24, 2024
·
6 min read
1 of 59,430
Next
